JPRN-UMIN000016302已完成未知
A Phase I/II Trial of Combined Chemotherapy with S-1 and Irinotecan in Patients with Recurrent Cervical Cancer. - A Phase I/II Trial of Chemotherapy with S-1 and Irinotecan For Recurrent Cervical Cancer.
Dept of Obstetrics and Gynecology, Osaka University Hospital.0 个研究点目标入组 30 人开始时间: 2015年1月22日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •Platinum-sensitive recurrent cervical cancer
研究者
相似试验
招募中
2 期
Phase II study of combination chemotherapy with S-1 plus Avastin in unresectable or recurrent colorectal cancer after failure of prior chemotherapy, including irinotecan and oxaliplatin regimens.colorectal cancerJPRN-UMIN000002308Translational Research Informatics Center(TRI)40
招募中
2 期
Phase II Study of combination chemotherapy with SPT in patient with HER2(+) advanced gastric cancerJPRN-UMIN000011595Kawasaki Gastric Cancer Group(KGCG)15
已完成
1 期
A phase 1 study of a combination chemotherapy, Sorafenib and intrahepatic arterial infusion of IA-call® (DDP-H), for advanced hepatocellular carcinoma.Hepatocellular carcinomaJPRN-UMIN000003831iigata Hepatocellular Carcinoma Therapy Study Group15
已完成
1 期
Phase I-II study of combination chemotherapy with Irinotecan and Gemcitabine for clear cell or mucinous ovarian cancerClear cell or mucinous ovarian cancerJPRN-UMIN000005952Osaka university, faculty of medicine40
已完成
1 期
Phase I/II study of combination chemotherapy with Paclitaxel and TS-1 and Cisplatin for unresectable/ recurrent gastric cancerunresectable or recurrent gastric cancerJPRN-UMIN000004729School of Medicine, Keio University40